A comprehensive study on: Allopathy and herbal therapy on breast cancer

Mainak Khan *, Deeparani Urolagin, Ansari Aashif Raza Mohd Imtiyaz, Samir Panda and Maneswari Boro

Department of Pharmacology, R R College of Pharmacy, Bangalore India.
 
Review
International Journal of Science and Research Archive, 2024, 12(01), 2863–2873.
Article DOI: 10.30574/ijsra.2024.12.1.0873
Publication history: 
Received on 09 April 2024; revised on 18 May 2024; accepted on 21 May 2024
 
Abstract: 
Without a question, the two most significant biological targets for breast cancer are HER2 and CDK4/6. Anti-HER2 therapies improve overall survival, progression-free/disease-free survival, and objective response. Overall survival statistics are still pending, but three CDK4/6 inhibitors regularly increase progression-free survival and objective response. There is still a need for better endocrine therapies and chemotherapy optimisation. Particularly for triple-negative breast cancer, check point inhibitor-based immunotherapy in conjunction with chemotherapy is a promising area.
 
Keywords: 
Herbal medicines; Anti-tumor; Anti-oxidant; Immune-suppressive; Flavonoids; Cancer; Phytochemicals; Camptothecin; Ixora; Anticancer activity
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0